0414 Results From an On-Road Driving Performance Study In Non-elderly And Elderly Healthy Subjects with Dual Orexin Receptor Antagonist Lemborexant

A. Vermeeren, E. Vuurman, S. Jongen, C. Van Leeuwen, A. Van Oers, J. Ramaekers, P. Murphy, M. Moline, C. Perdomo, K. Pinner

Research output: Contribution to journalConference Abstract/Poster in journalAcademic


Sedating cns-active drugs are typically studied for the potential to impair next-morning driving. Data from an on-road driving performance study are presented for lemborexant (lem), a dual orexin receptor antagonist under development for insomnia disorder.
Original languageEnglish
Pages (from-to)A157
Number of pages1
JournalSleep (Online)
Issue numberSuppl. 1
Publication statusPublished - 27 Apr 2018
Event32nd Annual Meeting of the Associated Professional Sleep Societies, LLC - Baltimore, United States
Duration: 2 Jun 20186 Jun 2018

Cite this